Financial Consulate, Inc Bio Techne Corp Transaction History

Financial Consulate, Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 17, 2023	BUY	$71.62 - $86.62 $77,994 - $94,329	1,089 Added 21.56%	6,141 $455,000
Q4 2022 Jan 11, 2023	BUY	$80.67 - $352.29 $308,320 - $1.35 Million	3,822 Added 310.73%	5,052 $0
Q3 2022 Oct 20, 2022	BUY	$282.54 - $391.85 $11,301 - $15,674	40 Added 3.36%	1,230 $349,000
Q2 2022 Jul 19, 2022	BUY	$322.67 - $449.65 $66,792 - $93,077	207 Added 21.06%	1,190 $413,000
Q1 2022 Apr 28, 2022	BUY	$353.85 - $487.79 $11,323 - $15,609	32 Added 3.36%	983 $426,000
Q4 2021 Feb 07, 2022	BUY	$456.15 - $525.06 $4,105 - $4,725	9 Added 0.96%	951 $492,000
Q3 2021 Oct 19, 2021	BUY	$444.87 - $538.88 $44,931 - $54,426	101 Added 12.01%	942 $456,000
Q2 2021 Jul 22, 2021	BUY	$387.35 - $450.26 $1,162 - $1,350	3 Added 0.36%	841 $379,000
Q1 2021 Apr 19, 2021	BUY	$314.62 - $411.0 $49,080 - $64,116	156 Added 22.87%	838 $320,000
Q4 2020 Jan 29, 2021	BUY	$246.9 - $321.87 $168,385 - $219,515	682 New	682 $217,000

601

151M

195K

53.2K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.8B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Financial Consulate, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Consulate, Inc with notifications on news.